Nurix Therapeutics (NRIX) Treasury Shares (2019 - 2026)

Nurix Therapeutics (NRIX) has 8 years of Treasury Shares data on file, last reported at $3.4 million in Q1 2026.

• Treasury Shares for Q1 2026 came in at $3.4 million, up 11.5% year-over-year; the trailing twelve-month figure through Feb 2026 was $3.4 million (up 11.5% YoY), and the FY2025 annual result was $2.2 million, up 14.82% from the prior year.
• Treasury Shares improved to $3.4 million in Q1 2026 per NRIX's latest filing, from $2.2 million in the prior quarter.
• Over five years, Treasury Shares peaked at $3.4 million in Q1 2026 and troughed at $1548.0 in Q1 2024.
• A 5-year average of $1.7 million and a median of $1.6 million in 2023 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares tumbled 99.9% in 2024, then jumped 195381.91% in 2025.
• A 5-year view of Treasury Shares shows it stood at $784824.0 in 2022, then surged by 58.77% to $1.2 million in 2023, then jumped by 56.98% to $2.0 million in 2024, then grew by 14.82% to $2.2 million in 2025, then jumped by 50.23% to $3.4 million in 2026.
• Business Quant data shows NRIX's Treasury Shares at $3.4 million in Q1 2026, $2.2 million in Q4 2025, and $2.7 million in Q3 2025.